Group Leader
Marco Herling, MD
News
Future therapies in T-PLL and T-LGL
June 7, 2021New perspective on future targeted therapy approaches published.
New article accepted for publication
August 30, 2020Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood
Alkylating deacetylase inhibitor tinostamustine in T-PLL
March 11, 2020New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.
Advances and Perspectives in the Treatment of T-PLL
February 25, 2020New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports
